Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Babaodan overcomes cisplatin resistance in cholangiocarcinoma via inhibiting YAP1

4 Apr 2024

Abstract excerpt

CONTEXT: Cholangiocarcinoma with highly heterogeneous, aggressive, and multidrug resistance has a poor prognosis. Although babaodan (BBD) combined with cisplatin improved non-small cell lung cancer efficacy, its impact on overcoming resistance in cholangiocarcinoma remains unexplored. OBJECTIVE: This study explored the role and mechanism of BBD on cisplatin resistance in cholangiocarcinoma cells (CCAs). MATERIALS...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cholangiocarcinoma and Gallbladder Cancer Studies
Share to Hippo pathway signaling and YAP/TAZ
Share to Histone Deacetylase Inhibitors Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38571483
DOI: 10.1080/13880209.2024.2331060

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Babaodan overcomes cisplatin resistance in cholangiocarcinoma via inhibiting YAP1PMID 38571483Read ↗

The Drug-Resistance Mechanisms of Five Platinum-Based Antitumor AgentsSemantic proximity Read ↗

A Naphthoquinone Compound Triggers Dna Damage-induced Apoptosis on Cholangiocarcinoma Through Upregulation of Bax and DR5Semantic proximity Read ↗

Drug Resistance in Hepatocellular Carcinoma: Theoretical Basis and Therapeutic AspectsSemantic proximity Read ↗

Antiproliferative and apoptotic effects of xanthohumol in cholangiocarcinomaSemantic proximity Read ↗

DNMT mRNA stability and YB-1 cooperatively regulate ABCB1 to drive cisplatin chemoresistance in cholangiocarcinomaSemantic proximity Read ↗

ABT737 enhances cholangiocarcinoma sensitivity to cisplatin through regulation of mitochondrial dynamicsSemantic proximity Read ↗

Hydroxychloroquine Induces Apoptosis in Cholangiocarcinoma via Reactive Oxygen Species Accumulation Induced by Autophagy InhibitionSemantic proximity Read ↗

Radioresistance in Hepatocellular Carcinoma: Biological Bases and Therapeutic ImplicationsSemantic proximity Read ↗

DNA Damage Response Inhibitors in Cholangiocarcinoma: Current Progress and PerspectivesSemantic proximity Read ↗

Autophagy modulating agents as chemosensitizers for cisplatin therapy in cancerSemantic proximity Read ↗

Elucidating Role of Reactive Oxygen Species (ROS) in Cisplatin Chemotherapy: A Focus on Molecular Pathways and Possible Therapeutic StrategiesSemantic proximity Read ↗

Can Cisplatin Therapy Be Improved? Pathways That Can Be TargetedSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.